Time to switch from CLSI to EUCAST? a Southeast Asian perspective
Despite the importance of antimicrobial susceptibility testing (AST) to clinical management of infection and to antimicrobial resistance (AMR) surveillance, methodologies and breakpoints of the two most commonly used systems worldwide, CLSI and EUCAST, are far from harmonized. Most laboratories in r...
Egile Nagusiak: | Cusack, T, Ashley, E, Ling, C, Roberts, T, Turner, P, Wangrangsimakul, T, Dance, D |
---|---|
Formatua: | Journal article |
Hizkuntza: | English |
Argitaratua: |
Elsevier
2019
|
Antzeko izenburuak
-
Impact of CLSI and EUCAST breakpoint discrepancies on reporting of antimicrobial susceptibility and AMR surveillance
nork: Cusack, T-P, et al.
Argitaratua: (2019) -
Effect of Differences in the CLSI and EUCAST Criteria on the Interpretation of Enterobacteriaceae Sensitivity to Carbapenems
nork: L. A. Kornoukhova, et al.
Argitaratua: (2021-10-01) -
Evaluations of Antifungal Susceptibilities Have to Be According to Reference Guidelines: CLSI and EUCAST
nork: Ali Korhan Sığ
Argitaratua: (2022-01-01) -
Estudo comparativo entre as metodologias preconizadas pelo CLSI e pelo EUCAST para avaliação da atividade antifúngica Comparative study of the recommended methodologies by CLSI and EUCAST for activity evaluation antifungal
nork: Marcos Aurélio Stoppa, et al.
Argitaratua: (2009-01-01) -
Novedades CLSI y EUCAST 2024 sobre detección y uso de antibióticos
nork: Diego Herrera, et al.
Argitaratua: (2024-08-01)